Treating hyperkalemia in patients with HF

10' education - Sep. 26, 2023 - Mikhail Kosiborod, MD - Kansas City, MO, USA

Video navigation menu

Clinical case 00:16
Treatment options for hyperkalemia 05:01
Novel potassium binders: patiromer and SZC 07:38
Summary 11:58

Educational information

This lecture by Mikhail Kosiborod, MD was part of the EBAC-accredited symposium "Tackling the risk of hyperkalemia through guideline-recommended heart failure therapy" held at the ESC Congress 2023, Amsterdam, The Netherlands.

Faculty

Mikhail Kosiborod, MD is a Cardiologist and Vice President of Research at Saint Luke’s Health System, Executive Director of the Cardiometabolic Center Alliance, Director of Cardiometabolic Research and Co-Director of the Haverty Cardiometabolic Center of Excellence at Saint Luke’s Mid America Heart Institute, and Professor of Medicine at the University of Missouri-Kansas City.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Funding

Funding for this educational program was provided by an unrestricted educational grant from AstraZeneca.

Find here the slides of the presentation Watch the other videos of this series

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.